LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

Search

Elanco Animal Health Inc

Cerrado

SectorSalud

18.51 3.23

Resumen

Variación precio

24h

Actual

Mínimo

18.4

Máximo

18.83

Métricas clave

By Trading Economics

Ingresos

-56M

11M

Ventas

48M

1.2B

P/B

Media del Sector

20.216

35.724

Margen de beneficio

0.886

Empleados

9,000

EBITDA

3M

264M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+1.51% upside

Dividendos

By Dow Jones

Próximas Ganancias

6 nov 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

1.9B

8.8B

Apertura anterior

15.28

Cierre anterior

18.51

Noticias sobre sentimiento de mercado

By Acuity

25%

75%

44 / 372 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

Elanco Animal Health Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

5 may 2025, 11:29 UTC

Adquisiciones, fusiones, absorciones

Elanco Sells Non-Core Asset to Blackstone for $295 Million

5 may 2025, 11:14 UTC

Adquisiciones, fusiones, absorciones

Elanco Sells Non-Core Asset to Blackstone for $295 Mln

5 may 2025, 10:50 UTC

Adquisiciones, fusiones, absorciones

Elanco Animal Health: Monetization of This Non-Core Asset Will Be Used to Accelerate Debt Reduction >ELAN

5 may 2025, 10:49 UTC

Adquisiciones, fusiones, absorciones

Elanco Sells Royalty and Milestone Rights for Lotilaner in Human Health to Blackstone for $295M

Comparación entre iguales

Cambio de precio

Elanco Animal Health Inc Esperado

Precio Objetivo

By TipRanks

1.51% repunte

Estimación a 12 meses

Media 18.17 USD  1.51%

Máximo 21 USD

Mínimo 15 USD

De acuerdo con 10 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Elanco Animal Health Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

10 ratings

7

Comprar

3

Mantener

0

Vender

Puntuación técnica

By Trading Central

9.77 / N/ASoporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Strong Bullish Evidence

Largo Plazo

Weak Bullish Evidence

Sentimiento

By Acuity

44 / 372 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Elanco Animal Health Inc

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.